Gouvernance BioCryst Pharmaceuticals, Inc.

BCRX

US09058V1035

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 09/07/2026			Varia. 5j.	Varia. 1 janv.
10,72 ^USD	-3,51%		+8,94%	+37,44%

07/07	BIOCRYST PHARMACEUTICALS, INC. : RBC Capital Markets toujours positif	ZM
29/06	BioCryst abandonne ses programmes de recherche interne et mise sur les partenariats pour réduire ses coûts	RE

Comité Exécutif: BioCryst Pharmaceuticals, Inc.

Dirigeant

Fonctions occupéesDepuis

Charles Gayer

55 ans

Chief Executive Officer	01/01/2026
President	01/08/2025

Babar Ghias

47 ans

Director of Finance/CFO

07/07/2025

Alane Barnes

60 ans

General Counsel	01/07/2006
Corporate Secretary	01/01/2007

Stephanie Angelini

Human Resources Officer	01/11/2018
Public Communications Contact	-

Sandeep Menon

51 ans

Chief Tech/Sci/R&D Officer

06/04/2026

Composition du Conseil d'Administration: BioCryst Pharmaceuticals, Inc.

Administrateur

ComitésDepuis

Vin Milano Milano

62 ans

Audit Committee Chair
Audit Committee	29/12/2025
Finance Committee Chair	29/12/2025

Theresa Heggie

64 ans

Audit Committee	02/06/2026
Governance Committee
Nominating Committee
Compensation Committee Chair	18/05/2023
Governance Committee Chair	18/05/2023
Nominating Committee Chair	18/05/2023

A. Sanders

62 ans

Compensation Committee Chair
Compensation Committee	22/08/2024
Governance Committee Chair	13/05/2025
Nominating Committee Chair	13/05/2025

Steven Galson

69 ans

Compensation Committee
Governance Committee Chair	01/09/2021
Nominating Committee Chair	01/09/2021

Amy McKee

54 ans

Governance Committee	20/09/2021
Nominating Committee	20/09/2021

Alan Levin

64 ans

Audit Committee Chair

Jill Milne

58 ans

Compensation Committee

23/01/2026

Charles Gayer

55 ans

Director/Board Member

01/01/2026

Steven Frank

66 ans

Director/Board Member

02/05/2025

Jon Stonehouse

65 ans

Director/Board Member

01/01/2007

Dernières Nominations: BioCryst Pharmaceuticals, Inc.

06/04	BioCryst Pharmaceuticals nomme Sandeep M. Menon au poste de Chief Research and Development Officer	CI
23/01	BioCryst Pharmaceuticals, Inc. nomme Jill C. Milne au sein de ses comités de rémunération et scientifique, à compter du 23 janvier 2026	CI
23/01	BioCryst Pharmaceuticals finalise l'acquisition d'Astria Therapeutics pour environ 720 millions de dollars	CI
23/01	BioCryst Pharmaceuticals, Inc. annonce des changements au sein de son conseil d'administration et de sa direction	CI
08/01	Praxis Precision Medicines, Inc. annonce des changements au sein de sa direction	CI
11/12	Biocryst Pharmaceuticals, Inc. annonce la retraite de Nancy J. Hutson, Ph.D., et lélection de Vincent J. Milano comme prochain président du conseil d'administration	CI
03/11	BioCryst Pharmaceuticals, Inc. nomme Ron Dullinger au poste de Chief Commercial Officer à compter du 1er janvier 2026	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: BioCryst Pharmaceuticals, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Donald Fong

Chief Tech/Sci/R&D Officer	01/04/2024	01/01/2026
Corporate Officer/Principal	01/04/2024	05/09/2024

Nancy Hutson

Director/Board Member	20/01/2012	31/03/2023
Chairman	31/03/2023	29/12/2025
Independent Dir/Board Member	20/01/2012	29/12/2025

Helen Thackray

Director/Board Member	20/09/2019	19/03/2021
Chief Tech/Sci/R&D Officer	19/03/2021	01/09/2025
Independent Dir/Board Member	20/09/2019	19/03/2021

George Abercrombie

Director/Board Member	24/05/2017	12/06/2025
Chairman	31/05/2013	24/05/2017
Independent Dir/Board Member	24/05/2017	12/06/2025

Stephen Aselage

Director/Board Member	04/01/2019	12/06/2025
Independent Dir/Board Member	04/01/2019	12/06/2025

Anthony Doyle

Comptroller/Controller/Auditor	10/07/2023	09/04/2025
Director of Finance/CFO	02/04/2020	09/04/2025
Treasurer	-	09/04/2025

Ryan Arnold

Chief Tech/Sci/R&D Officer	15/09/2022	05/09/2024
Corporate Officer/Principal	01/03/2022	15/09/2022

Michael Jones

Comptroller/Controller/Auditor	01/01/2013	10/07/2023
Director of Finance/CFO	-	01/04/2024

Kenneth Lee

Director/Board Member	28/06/2011	31/12/2023
Independent Dir/Board Member	27/06/2011	31/12/2023

Allen Hodge

Corporate Officer/Principal

15/01/2020

01/07/2022

Megan Sniecinski

Corporate Officer/Principal

01/07/2019

09/08/2021

Elliott T. Berger

General Counsel

08/08/2007

01/04/2021

Salisa Hauptmann

General Counsel

01/01/2021

Thomas Staab

Comptroller/Controller/Auditor	01/07/2011	08/01/2020
Director of Finance/CFO	05/07/2011	29/02/2020
Investor Relations Contact	01/07/2011	-
Treasurer	01/07/2011	29/02/2020

Lynne Powell

Corporate Officer/Principal

26/01/2015

01/07/2019

John D. Bluth

Public Communications Contact

01/04/2019

Fred Cohen

Director/Board Member	21/07/2013	04/01/2019
Independent Dir/Board Member	21/07/2013	04/01/2019

Stanley Erck

Director/Board Member	01/12/2008	03/12/2018
Independent Dir/Board Member	01/12/2008	03/12/2018

Sanj Patel

Director/Board Member	29/09/2015	20/06/2018
Independent Dir/Board Member	29/09/2015	20/06/2018

Robert Bennett

Chief Operating Officer	-	01/05/2017
Investor Relations Contact	04/05/2011	-
Public Communications Contact	-	01/05/2017

Andreas Maetzel

Corporate Officer/Principal

01/08/2014

01/02/2017

Jason Adair

Corporate Officer/Principal

01/08/2011

01/12/2015

Robert Alexander Ingram

Director/Board Member	05/08/2015	24/05/2017
Chairman	04/05/2017	-
Independent Dir/Board Member	05/08/2015	-

Peder Jensen

Director/Board Member	03/05/2011	01/05/2015
Independent Dir/Board Member	03/05/2011	01/05/2015

Zola Horovitz

Director/Board Member	01/08/1994	13/05/2009
Chairman	13/05/2009	31/05/2013
Independent Dir/Board Member	01/08/1994	31/05/2013

John Higgins

Director/Board Member	01/05/2004	-
Independent Dir/Board Member	01/01/1994	-

Robert S. Lowrey

Comptroller/Controller/Auditor	07/03/2011	25/01/2013
General Counsel	07/03/2011	10/03/2011

David S. McCullough

Corporate Officer/Principal

01/04/2007

12/12/2012

Stephen Biggar

Director/Board Member

03/10/2005

10/10/2011

Stuart R. Grant

Director of Finance/CFO

27/08/2007

30/06/2011

Beth Seidenberg

Director/Board Member

15/12/2005

12/05/2011

William W. Featheringill

Director/Board Member

01/05/1995

27/04/2011

J. Michael Mills

Comptroller/Controller/Auditor

01/01/2005

18/02/2011

Julie Daves

Corporate Officer/Principal

01/04/2007

01/01/2011

Charlie Sanders

Director/Board Member	11/12/2009	-
Independent Dir/Board Member	08/12/2009	-

Peter L. McCullough

Chief Operating Officer

15/02/2010

Randolph Steer

Director/Board Member

01/01/2009

Michael A. Darwin

Comptroller/Controller/Auditor	01/06/2000	31/12/2008
Director of Finance/CFO	01/06/2000	31/12/2008
Treasurer	01/06/2000	31/12/2008

William Sheridan

Chief Tech/Sci/R&D Officer	01/07/2008	15/09/2022
Corporate Officer/Principal	15/09/2022	-

J. Claude Bennett

Director/Board Member

01/12/1996

13/06/2008

Robert C. Stoner

Human Resources Officer

01/01/2008

Randall B. Riggs

Corporate Officer/Principal

01/02/2005

12/10/2007

Charles E. Bugg

Chairman	01/01/1986	20/05/2007
Founder	01/01/1986	20/05/2007

Carl Gordon

Director/Board Member

01/05/2007

Walter G. Gowan

Corporate Officer/Principal

13/05/2009

William James Alexander

Chief Tech/Sci/R&D Officer	01/06/2006	-
General Counsel	01/06/2006	01/06/2006

Jonathan M. P. Nugent

Public Communications Contact

01/05/2005

Tacey Viegas

Corporate Officer/Principal

01/07/1994

01/01/2002

Carol H. Danielson

General Counsel

01/01/1993

01/01/1999

Joseph H. Sherrill

Director/Board Member

01/05/1995

Frederick J. Dechow

Chief Executive Officer	01/01/1990	01/01/1994
President	01/01/1990	-

Yarlagadda Babu

Corporate Officer/Principal

01/01/1988

John A. Montgomery

Director/Board Member	01/01/1986	-
Founder	01/01/1986	-

William M. Spencer

Director/Board Member	01/01/1986	-
Founder	01/01/1986	-

John A. Secrist

Corporate Officer/Principal

A. K. Schleusner

Public Communications Contact

04/08/2009

Shakil Aslam

Chief Tech/Sci/R&D Officer

Catherine Kyroulis

Public Communications Contact

Kavita Aggarwal

Corporate Officer/Principal

Mike Mills

Comptroller/Controller/Auditor

Thomas J. Simon

Chief Tech/Sci/R&D Officer

John R. Uhrin

Corporate Officer/Principal

Brian Spar

Corporate Officer/Principal

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	14
Femme	5

Dont comité exécutif

Homme	3
Femme	2

Dont Administrateurs

Homme	8
Femme	2

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

BioCryst Pharmaceuticals, Inc. est une société de biotechnologie spécialisée dans le développement et la commercialisation de médicaments destinés au traitement de l’œdème angioneurotique héréditaire (HAE) et d’autres maladies rares. Parmi ses produits commercialisés figurent ORLADEYO, un médicament oral à prise unique quotidienne destiné à la prévention des crises d’HAE, ainsi que RAPIVAB (peramivir injectable), utilisé aux États-Unis pour le traitement de la grippe aiguë sans complication. Parmi ses autres produits et produits candidats figurent le BCX17725, le navenibart, l’Avoralstat, le STAR-0310, le RAPIACTA (injection de peramivir) et le PERAMIFLU (injection de peramivir). Le RAPIVAB (injection de peramivir) est autorisé aux États-Unis pour le traitement de la grippe aiguë non compliquée chez les patients âgés de six mois et plus. Le peramivir injectable est également approuvé au Canada (RAPIVAB), en Australie (RAPIVAB), au Japon (RAPIACTA), à Taïwan (RAPIACTA) et en Corée (PERAMIFLU). La société a également obtenu un programme de phase précoce pour le traitement de la dermatite atopique (DA), le STAR0310.

Employés

435

Secteur

Recherche biotechnologique et médicale

Plus d'informations sur la société